Preclinical AIDS vaccine development: Formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates

Journal of Medical Primatology

Volumn 26, Issue 1-2, 1997, Pages 63-81

  Warren, Jonathan T ^a   Levinson, Mark A ^a  

^a EMMES CORPORATION   (United States)

Author keywords

AIDS vaccine surveillance system (AVSS); Baboons; Chimpanzees; Macaques; NHP

Indexed keywords

MACACA; PAN (APE); PAPIO; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; FACTUAL DATABASE; GENETIC REASSORTMENT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFORMATION PROCESSING; MONKEY DISEASE; PRIMATE; RESEARCH; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION;

AIDS VACCINES; ANIMALS; DATA COLLECTION; DATABASES, FACTUAL; HIV; HIV INFECTIONS; PRIMATES; REASSORTANT VIRUSES; RESEARCH; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0031064734     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1997.tb00321.x     Document Type: Article

References (78)

1. ALMOND N, KENT K, CRANAGE M, RUD E, CLARKE B, STOTT EJ: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344, 1995.
2. ALMOND N, RUD E, KENT K, CHAN L, PAGE M, JONES W, MILLS K, CLARKE B, KITCHIN P, STOTT J: The molecular characterization of vaccine trials using recombinant envelope immunogens and live SIV containing distinct nef genes. 11th Annual Symposium of Nonhuman Primate Models for AIDS, Abstract No. 54, Sept. 19-22, 1993.
3. BENVENISTE RE, KULLER L, HU S-L, CLARK E, CLERICI M, SHEARER G, MORTON W: Prior exposure to subinfectious doses of SIV protects macaques from subsequent virus challenge. 11th Annual Symposium on Nonhuman Primate Models for AIDS, Abstract No. 8, Sept. 19-22, 1993.
4. BERMAN PW, MURTHY KK, WRIN T, VENNARI JC, COBB EK, EASTMAN J, CHAMPE M, NAKAMURA GR, DAVISON D, POWELL MF, BUSSIERE J, FRANCIS DP, MATHEWS T, GREGORY TJ, OBIJESKI JF: Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J Infect Dis 173:52-59, 1996.
5. BIBERFELD G, ANDERSSON S, PUTKONEN P, THORSTENSSON R, MAKITALO B, GILLJAM G, FRANCHINI G, TARTAGALIA J, PAOLETTI E: Protective immunity in cynomolgus monkeys immunized with canary pox HIV-2 vaccines and/or HIV-2 gp125. AIDS Res Hum Retro 10:S116 (Abstract No. 213), 1994.
6. BIBERFELD G, PUTKONEN P, THORSTENSSON R, GILLJAM G, AKERBLOM L, MOREIN B: Vaccination of cynomolgus macaques with native HIV-2 gp125. IX International Conference on AIDS, IV STD World Congress (Abstract) WS-A23-4:39, 1993.
7. BOGERS WMJM, NIPHLIS H, TEN HAAFT P, LAMAN JD, KOORNSTRA W, HEENEY JL: Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: Consequences of challenge. AIDS 9:F13-F18, 1995.
8. BOYER JD, WANG B, UGEN KE, AGADJANYAV M, JAVADIAN A, FROST P, DANG K, CARRANO RA, CICCARELLI R, CONEY L, WILLIAMS WV, WEINER DB: In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25:242-250, 1996.
9. CLEMENTS JE, MONTELARO RC, ZINK MC, AMEDEE AM, MILLER S, TRICHEL AM, JAGERSKI B, HAUER D, MARTIN LN, BOHM RP, MURPHEY-CORB M: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 69:2737-2744, 1995.
10. CLERICI M, CLARK EA, POLACINO P, AXBERG I, KULLER L, CASEY NI, MORTON WR, SHEARER GM, BENVENISTE RE: T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8:1391-1395, 1994.
11. CONLEY AJ, KESSLER JA II, BOOTS LJ, MCKENNA PM, SCHLEIF WA, EMINI EA, MARK GE III, KATINGER H, COBB EK, LUNCEFORD SM, ROUSE SR, MURTHY KA: The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J Virol 70:6751-6758, 1996.
12. GALLIMORE A, CRANAGE M, COOK N, ALMOND N, BOOTMAN J, RUD E, SILVERA P, DENNIS M, CORCORAN T, STOTT J, MCMICHAEL A, GOTCH F: Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1:1167-1173, 1995.
13. GARDNER MB: The history of simian AIDS. J Med Primatol 25:148-157, 1996.
14. GIAVEDONI LD, AHMAD S, MILLER C, IMHOOF J, PARODI L, YILMA T: SIVHyIFN is nonpathogenic for newborn macaques and induces protective immunity against challenge with virulent SIV. The 14th Annual Symposium on Nonhuman Primate Models for AIDS, Portland, OR, Abstract No. 97, p. 193, Oct. 23-26, 1996.
15. GIAVEDONI LD, LUCIW P, JONES L, AHMAD S, PARODI L, YILMA T: SIV delta-nef expressing IFN-gamma is a more attenuated and efficacious vaccine than SIV delta-nef. The 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 24, p. 88, Nov. 5-8, 1995.
16. GIRARD M, MEIGNIER B, BARRE-SINOUSSI F, KIENY M-P, MATTHEWS T, MUCHMORE E, NARA PL, WEI Q, RIMSKY L, WEINHOLD K, FULTZ PN: Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol 69:6239-6248, 1995.
17. GIRARD M, YUE L, BARRE-SINOUSSI F, VAN DER RYST E, MEIGNIER B, FULTZ PN: Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virol 70:8229-8233, 1996.
18. HAIGWOOD N, SUTTON W, MCCLURE J, WATSON A, RANCHALIS J, SCHEIBEL M, TRAVIS B, HU S-L, HIRSCH V, JOHNSON P: Effect of passive immune globulin treatment on viral replication, host immune responses, and disease in the SIV/macaque model. J Med Primatol 23:235 (Abstract No. 17), 1994.
19. HAIGWOOD N, WATSON A, SUTTON W, MCCLURE J, LEWIS A, RANCHALIS J, TRAVIS B, VOSS G, LETVIN NL, HU S-L, HIRSCH V, JOHNSON P: Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Letters 51:107-114, 1996.
20. HAIGWOOD NL, MONTEFIORI D, SUTTON W, WATSON A, MCCLURE J, HIRSCH VM, JOHNSON PR: Neutralizing antibody correlates with improved clinical outcome in passive IgG treatment of SIV-infected macaques. 14th Annual Symposium on Nonhuman Primate Models for AIDS, Portland, OR, Abstract No. 34, Oct. 23-26, 1996.
21. HAIGWOOD NL, WATSON A, MCCLURE J, SUTTON W, RANCHALIS J, TRAVIS B, LEWIS A, VOSS G, LETVIN N, HU SL, HIRSCH V, JOHNSON P: Passive immune globulin therapy during primary viremia in SIV-infected macaques reduces viral burden and delays disease. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 151, Nov. 5-8, 1995.
22. HEENEY J, HOLTERMAN L, TEN HAAFT P, KOORNSTRA W, DUBBES R, NIPHUIS H: Protection from heterologous macaque propagated SIV challenge. International Conference on Advances in AIDS Vaccine Development, 6th Annual Meeting of the National Cooperative Vaccine Development Groups, Abstract, Oct 30-Nov. 4, 1993.
23. HEENEY JL, HOLTERMAN L, TEN HAAFT P, DUBBES R, KOORVSTRA W, TEEUWSEN V, BOURQUIN P, NORLEY S, NIPHUIS H: Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Hum Retro 10:5117-5121, 1994.
24. HIRSCH VM, FUERST TR, SUTTER G, CARROLL MW, YANG LC, GOLDSTEIN S, PIATAK M JR, ELKINS W, ALVORD WG, MONTEFIORI DC, MOSS B, LIFSON J: Patterns of viral replication correlate with outcome in simian immunodeficiency virus-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 70:3741-3752, 1996.
25. HIRSCH VM, LIFSON J, MOSS B, CHANOCK R, ELKINS WR, FUERST T: Marked reduction in viral load in macaques immunized with an attenuated vaccinia virus expressing SIV gag-pol and env. J Med Primatol 23:267 (Abstract No. 110), 1994.
26. HU S-L, POLACINO P, STALLARD V, KALNIECKI J, PENNATHUR S, TRAVIS B, MISHER L, KORNAS H, LANGLOIS AJ, MORTON WR, BENVENISTE RE: Role of envelope and core antigens in protection against SIV. Conference on Advances in AIDS Vaccine Development, 7th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Presentation Abstract. Nov. 6-10, 1994.
27. HU S-L, POLACINO P, STALLARD V, KALNIECKI J, PENNATHUR S, TRAVIS B, MISHER L, KORNAS H, LANGLOIS AJ, MORTON WR, BENVENISTE RE: Role of immune responses to the envelope and the core antigens in the protection of macaques against infection by SIVmneE11S. J Med Primatol 23:239 (Abstract No. 26), 1994.
28. HU S-L, POLACINO P, STALLARD V, KLANIECKI J, PENNATHUR S, TRAVIS B, MISHER L, KORNAS H, LANGLOIS AJ, MORTON WR, BENVENISTE RE: Role of immune responses to the envelope and the core antigens in the protection of macaques against infection by SIVmneE11S. 12th Annual Symposium on Nonhuman Primate Models for AIDS, Boston, MA, Abstract/Poster No. 26, Oct. 12-15, 1994.
29. HU S-L, POLACINO P, STALLARD V, KLANIECKI J, PENNATHUR S, TRAVIS BM, MISHER L, KORNAS H, LANGLOIS AJ, MORTON WR, BENVENISTE RE: Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection. Immunol Lett 51:115-119, 1996.
30. HULSKOTTE EGJ, GERETTI A-M, SIEBELINK KHJ, VAN AMERONGEN G, CRANAGE MP, RUD EW, NORLEY SG, DE VRIES P, OSTERHUS ADME: Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J Virol 69:6289-6296, 1995.
31. JOHNSON RP: Macaque models for AIDS vaccine development. Cur Opin Immunol 8:554-560, 1996.
32. KLANIECKI JE, TRAVIS BM, WREY T, PENNATHUR S, THOMPSON JL, AGY MB, KULLER L, MONTEFIORI D, MORTON WR, HU S-L: Immune response to HIV-1 envelope and core antigens in protection of macaques against chimeric SHIV challenge. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 25, p 88, Nov. 5-8, 1995.
33. KLANIECKI JE, TRAVIS BM, WREY T, PENNATHUR S, THOMPSON JL, AGY MB, KULLER L, MONTEFIORI D, MORTON WR, HL S-L: Protective efficacy of HIV-1 envelope and core vaccines against SHIV-IIIB challenge. 14th Annual Symposium on Nonhuman Primate Models for AIDS, Portland, OR, Abstract No. 27, p 102, Oct. 23-26, 1996.
34. KULLER L, BENNENISTE RE, TSAI C-C, CLARK EA, POLACINO P, WATANABE R, OVERBAUGH J, KATZE MG, MORTON WR: Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS. J Med Primatol 23:397-409, 1994.
35. LAHCEN W, LE GRAND R, VASLIN B, CHERET A, MATHEUX F, THEODORO F, ROQUES P, NICOL I, DORMONT D: Superinfection of HIV-2-preinfected macaques after a traumatic rectal inoculation of SIVmac251. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 134, p 216, Nov. 5-8, 1995.
36. LEHNER T, WANG Y, CRANAGE M, BERGMEIER LA, MITCHELL E, TAO L, HALL G, DENNIS M, COOK N, BROOKES R, KAVINSKIS L, JONES I, DOYLE C, WARD R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 2:767-775, 1996.
37. LETVIN NL, LI J, HALLORAN M, CRANAGE MP, RUD EW, SODROSKI J: Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect against challenge with simian immunodeficiency virus. J Virol 69:4569-4571, 1995.
38. LEVY JA: The value of primate models for studying human immunodeficiency virus pathogenesis. J Med Primatol 25:163-174, 1996.
39. LOCHER CP, BLACKBOURN DJ, MURTHY KK, BARNETT SW, BRASKY KM, BUTLER TM, RICE K, CAREY KD, LEVY JA: Baboons infected with HIV-2 are resistant to superinfection. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 35, p 113, Nov. 5-8, 1995.
40. LU S, ARTOS J, MONTEFIORI D, YASUTOMI Y, MANSON K, MUSTAFA F, JOHNSON E, SANTORO JC, WISSINK J, MULLINS JI, HAYNES JR, LETVIN NL, WYAND M, ROBINSON HL: Simian immunodeficiency virus DNA vaccine trail in macaques. J Virol 70:3978-3991, 1996.
41. LU S, ROBINSON HL, MUSTAFA E, JOHNSON E, SANTORO JC, ARTOS J, WINSINK J, MULLINS JI, MONTEFIORI D, YASUHARI Y, LETVIN N, HAYNES JR, MANSON K, WYAND M: Simian immunodeficiency virus DNA vaccine trial in macaques. Conference on Advances in AIDS Vaccine Development, 7th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Abstract. Nov. 6-10, 1994.
42. LU S, ROBINSON HL: DNA vaccine: Anti-SIV immune responses in rhesus macaques. J Med Primatol 23:268 (Abstract No. 113), 1994.
43. LU Y, SALVATO MS, PAUZA CD, LI J, SODROSKI J, MANSON K, WYAND M, LETVIN N, JENKINS S, TOZJIAN N, CHUTKOWSKI C, KUSHNER N, LEFAILE M, PAYNE LG, ROBERTS B: Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J AIDS 12:99-106, 1996.
44. MARTHAS M, LOHMAN B, MILLER CJ, MCCHESNEY MB: Early events after vaginal transmission of simian immunodeficiency virus in naive and genitally immunized female rhesus macaques. J Med Primatol 23:257 (Abstract No. 79), 1994.
45. MARTHAS ML, VAN ROMPAY KKA, TARANTAL AF, REAY E, BERARDI CJ, TELM S, MCCHESNEY MB: Prevention of oral SIV transmission to rhesus neonates by maternal vaccination. 14th Annual Symposium on Nonhuman Primate Models for AIDS. Portland. OR. Abstract No. 31, p 110, Oct. 23-26, 1996.
46. MCCHESNEY MB, LOHMAN BL, MILLER CJ, TELM S, BERARDI C, REAY E, MARTHAS ML: Genital immunization with live-attenuated SIV protects against intravaginal challenge with virulent virus. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 138, p 216, Nov. 5-8, 1995.
47. MURTHY KK, COBB EK, ROUSE SR, LUNCEFORD SM, JOHNSON DE, GALVAN AR: Correlates of protective immunity against HIV infection in immunized chimpanzees. Immunol Lett 51:121-124, 1996.
48. MYAGKIKH M, ALIPANAH S, MARKHAM PD, TARTAGLIA J, PAOLETTI E, GALLO RC, FRANCHINI G, ROBERT-GUROFF M: Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques. AIDS Res Hum Retro 12:985-992, 1996.
49. NILSSON C, THORSTENSSON R, GILLIAM G, SJOLANDER S, HILD K, BROLIDEN K, AKERBLOM L, MOREIN B, BIBERFELD G, PUTKONEN P: Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Res 4:165-175, 1995.
50. NIPHUIS H, HEENEY JL: Protection from viremia and disease progression in SIVbk28 infected Macaca mulatta, challenged with SIVmac251/32H. VII International Conference on AIDS. IV STD World Congress, Abstract M.A.1264:158, 1991.
51. NORLEY S, BEER B, BINNINGER-SCHINZEL D, COSMA C, KURTH R: Protection from SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Conference on Advances in AIDS Vaccine Development, 7th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Presentation Abstract, p 213, Nov. 6-10, 1994.
52. NORLEY S, BEER B, BINNINGER-SCHINZEL D, COSMA C, KURTH R: Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 219:195-205, 1996.
53. OTSYULA MG, MILLER CJ, TARAVTAL AF, MARTHAS ML, GREENE TP, COLLINS JR, VAN ROMPAY KKA, MCCHESNEY MB: Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology 222:275-278, 1996.
54. PAUZA CD, MALKOVSKY M, SALVATO MS: SIV transmission across the mucosal barrier. AIDS Res Hum Retro 10:S7-S10, 1994.
55. POLACINO P, KLANIECKI J, PENNATHUR S, STALLARD V, KORNAS H, LANGLOIS AJ, MORTON WR, BENVENISTE RE, HU S-L: Immune responses to SIVmne core antigens broadens the protective immunity elicited by envelope (gp160) vaccines. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 141, Nov. 5-8, 1995.
56. PUTKONEN P, NILSSON C, MAKITALO B, BIBERFELD G, CRANAGE M, RUD E: Immunization with live attenuated SIVmac can protect macaques against mucosal infection with SIVsm. In: Norrby E, Brown F, Chanock RM, Ginsberg HS (eds): Vaccines 96, Modern Approaches to New Vaccines Including Prevention of AIDS. New York: Cold Spring Harbor Laboratory Press, 1997 (in press).
57. PUTKONEN P, THORSTENSSON R, BIBERFELD G: Infection of macaques with HIV-2 prevents SIV-induced disease, but fails to protect against SIV infection. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 142, p 224, Nov. 5-8, 1995.
58. PUTKONEN P, WALTHER L, ZHANG Y-J, LI S-L, NILSSON C, ALBERT J, BIBERFELD P, THORSTENSSON R, BIBERFELD G: Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat Med 1:914-918, 1995.
59. PUTKONEN P, BJORLING E, AKERBLOM L, THORSTENSSON R, LOVGREN K, BENTHIN L, CHIODI F, MOREIN B, BIBERFELD G, NORRBY E, WIGZELL H: Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. J AIDS 7:551-559, 1994.
60. PUTKONEN P, MAKITALO B, THORSTENSSON R, BIBERFELD G: Efficacy studies of live attenuated HIV-2 and SIV vaccines in cynomolgus monkeys. J Med Primatol 23:269 (Abstract No. 116), 1994.
61. PUTKONEN P, BJORLING E, AKERBLOM L, BIBERFELD G, MOREIN B, NORRBY E, WIGZELL H: Protection of macaques against HIV-2 with a HIV-2 vaccine in ISCOMS. VII International Conference on ADDS, IV STD World Congress, Abstract PoA 2157:A29, 1992.
62. QUESADA-ROLANDER M, MAKITALO B, THORSTENSSON R, ZHANG Y-J, CASTANOS-VELEZ E, BIBERFELD G, PUTKONEN P: Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV Type 1 envelope. AIDS Res Hum Retro 12:993-999, 1996.
63. QUESADA-ROLANDER M, THORSTENSSON R, ZHANG Y-J, FENYO E-M, BIBERFELD G, PUTKONEN P: Protection against intrarectal SIVsm challenge in macaques preinfected with a chimeric HIV-1/SFV virus that expresses HIV-1 envelope. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 143, p 225, Nov. 5-8, 1995.
64. RUD EW, ALMOND N, OGILVIE LC, KENT K, CHAN L, PAGE M, WOOLON P, KITCHIN P, STOTT J, COOK N, SHARPE S, ASHWORTH LAE, DENNIS M, HALL G, CRANAGE MP, CLARKE BE: A naturally attenuated SIVmac32H vaccine or viral interference? In: Norrby E, Brown F, Chanock RM, Ginsberg HS (eds): Vaccines 94, Modern Approaches to New Vaccines Including Prevention of AIDS. New York: Cold Spring Harbor Laboratory Press, 217-223, 1994.
65. SALVATO MS, EMAU P, MALKOVSKY M, SCHULTZ KT, JOHNSON E, PAUZA CD: Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J Med Primatol 23:125-130, 1994.
66. SCHMIDT A, MORTON WR, HL S-L, GREENBERG P, ROBERTSON M, MCCLURE J, KRAUS G, LOONEY D, WONG-STAAL F: HIV-2/287: A pathogenic isolate of HIV-2 used as a challenge virus for vaccine testing. 13th Annual Symposium on Non-human Primate Models for AIDS, Monterey, CA, Abstract No. 144, p 226, Nov. 5-8, 1995.
67. SHIBATA R, SIEMON C, CHO MW, ARTHUR LO, NIGIDA SM JR, MATTHEWS T, SAWYER LA, SCHULTZ A, MURTHY KK, ISRAEL Z, JAVADIAN A, FROST P, KENNEDY RC, LANE HC, MARTIN MA: Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol 70:4361-4369, 1996.
68. STAHL-HENNIG C, DITTMER U, NIBLEIN T, PEKRUN K, PETRY H, JURKIEWICZ E, FUCHS D, WACHTER H, RUD EW, HUNSMANN G: Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion. Immunol Lett 51:129-135, 1996.
69. SUTTON WF, KLANIECKI J, MCCLURE J, WATSON A, PENNATHUR S, HIRSCH VM, JOHNSON PR, HU S-L, HAIGWOOD NL: In vitro analysis of passively administered immune globulin and de novo humoral immune responses in SIV-infected macaques. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 12, Nov. 5-8, 1995.
70. TRIVEDI P, HOREISH D, HINDS SB, HINDS PW II, WU MS, SALVATO MS, PAUZA CD: Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: Selective amplification and host responses to transient or persistent viremia. J Virol 70:6876-7883, 1996.
71. VAN ROMPAY KKA, BERARDI CJ, OTSYULA M, MCHESNEY M, HARESCO J, TELM S, MARTHAS ML: Passive immunization with anti-SIV hyperimmunoglobulin protects newborn rhesus macaques against oral SIV infection. 13th Annual Symposium on Nonhuman Primate Models for AIDS, Monterey, CA, Abstract No. 155, p 238, Nov. 5-8, 1995.
72. VAN ROMPAY KKA, OTSYULA MG, TARARA RP, CANFIELD DR, BERARDI CJ, MCCHESNEY MB, MARTHAS ML: Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J Infect Dis 173:1327-1335, 1996.
73. WALTHER L, FREDLUND H, BIBERFELD G, THORSTENSSON R, PUTKONEN P: Cross-protection against SIVsm in HIV-2 vaccinated cynomolgus monkeys. Keystone Symposia on Molecular and Cellular Biology: Immunopathogenesis of HIV Infection, Hilton Head, SC, Poster Presentation, Mar. 26-April 1, 1996.
74. WARREN JT, LEVINSON MA: Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol 24:150-168, 1995.
75. WARREN JT, DOLATSHAHI M: Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol 23:184-225, 1994.
76. WARREN JT, DOLATSHAHI M: First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: Progress in first and second order studies. J Med Primatol 22:203-235, 1993.
77. WARREN JT: The impetus for tracking nonhuman primate AIDS vaccine/live virus challenge studies. J Med Primatol 21:138, 1992.
78. WARREN JT, DOLATSHAHI M: Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: Vaccines associated with active and passive immune protection from live virus challenge. J Med Primatol 21:139-186, 1992.